Skip to content

Nicotine Delivery Systems: Research & Treatment

Nicotine Delivery Systems: Research and Treatment

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00108342
Acronym
NDS
Enrollment
25
Registered
2005-04-15
Start date
2007-10-31
Completion date
2009-12-31
Last updated
2014-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

nicotine, drug therapy, Smoking Cessation

Brief summary

The purpose of this study is to determine whether sampling nicotine replacement treatments (NRTs) is superior to learning about them by computer. Testing also covers preferences among the treatments. Subjects will be enrolled veterans who smoke. Hypothesis: Direct experience (sampling) of NRTs will increase knowledge about NRTs, motivation/confidence, use of NRTs and quit attempts in contrast to learning about NRTs by computer.

Detailed description

The study was designed to compare sampling of several nicotine replacement treatments (NRTs) in contrast to a computer learning control. The NRTs include: 2 dosages of nicotine gum, 2 dosages of nicotine lozenges and 2 dosages of oral nicotine inhalers. In the sampling group, each participant tries each of the 6 NRTs for 3 minutes. In the control, the individuals read about the treatments. Dependent measures include: quit attempts, use of NRTs, preferences among NRTs, and learning and motivation.

Interventions

DRUGNicotine gum - 2 mg and 4 mg
DRUGNicotine lozenges - 2 mg and 4 mg
DRUGNicotine inhaler (4 mg yield) - low and high dosage by frequency of puffing

can yield 4 mg from 10 mg device - infrequent and frequent puffing

OTHERComputer learning

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be enrolled veteran who smokes.

Exclusion criteria

* Any event or condition that could be exacerbated by the local effects of nicotine treatments (e.g., throat or stomach problems; any kind of wheezing from a condition or medication) * other criteria as determined by PI and study physicians * reactions to menthol (inhaler) or to aspartame (lozenge)

Design outcomes

Primary

MeasureTime frameDescription
Quit Attempts, Use of NRTs, Preference Among NRTsAt testing, at follow-upIn addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.

Countries

United States

Participant flow

Pre-assignment details

25 enrollees gave their signed consent and were then screened for participation; a total of 17 participated in testing.

Participants by arm

ArmCount
NRT Sampling
Sampling = actual 3 minute testing of each of 6 NRTs (3 forms x 2 dosages) Nicotine gum - 2 mg and 4 mg Nicotine lozenges - 2 mg and 4 mg Nicotine inhaler - infrequent and frequent puffing for dosage (can yield 4 mg from 10 mg device)
8
NRT Computer Learning
Computer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only
9
Total17

Baseline characteristics

CharacteristicNRT SamplingNRT Computer LearningTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants9 Participants17 Participants
Region of Enrollment
United States
8 participants9 participants17 participants
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
7 Participants9 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 80 / 0
serious
Total, serious adverse events
0 / 80 / 0

Outcome results

Primary

Quit Attempts, Use of NRTs, Preference Among NRTs

In addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.

Time frame: At testing, at follow-up

Population: The study was terminated and the data were not analyzed due to the small sample size.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026